The Latest Cardiac and Vascular News
LAKE FOREST, Calif.–(BUSINESS WIRE)–NaviGate Cardiac Structures Inc. (“NCSI”) announced today that on 2 Feb. 2018, its catheter-guided GATE™ valved-stent bioprosthesis beame the first Canadian orthotopic valve replacement to treat severe tricuspid regurgitation. The procedure was performed at the Quebec Heart and Lung Institute, Laval University (Quebec City, Canada) by the Institute’s […]
TEL AVIV, Israel, Feb. 23, 2018 /PRNewswire/ — Vascular Grafts Solutions announced today the interim results from the VEST III study, a post-marketing trial which evaluates the effectiveness of the VEST technology (Venous External SupporT) in treatment of saphenous vein graft (SVG) disease after coronary artery bypass grafting. The Interim […]
GALWAY, Ireland–(BUSINESS WIRE)– 4Tech Inc., a leader in the field of transcatheter tricuspid valve repair, announces changes in its leadership team: Tom Fleming will join the company as President and Chief Executive Officer (CEO), effective as of March 2018; and Keith D. Dawkins, M.D., has joined as Chief Medical Officer (CMO), effective immediately. Tom […]
“This preclinical demonstration that stent deployment of microcrystalline drug in combination with a rapidly absorbable polymer, such as with MiStent, results in more uniform drug dosing that could lead to more rapid and uniform healing across the treated segment,” said David Kandzari, M.D., Director of Interventional Cardiology and Chief Scientific Officer, Piedmont […]
Study Expected to Expand to Five Hospitals and Evaluate Accuracy of the VIVO System LEDGEWOOD, N.J., Feb. 20, 2018 /PRNewswire/ — Catheter Precision, Inc.. announces the initiation of a pivotal clinical trial to assess the accuracy and safety of the VIVO™ (View Into Ventricular Onset) Non-Invasive Mapping System. The VIVO system […]
Mitralign raises $10m FEBRUARY 21, 2018 BY BRAD PERRIELLO, MassDevice Mitralign, which is looking to commercialize its namesake mitral valve treatment and pursue regulatory nods for its Trialign tricuspid valve device, said it raised nearly $10 million. The $9.8 million funding, of a hoped-for $30.2 million, came from 19 unnamed investors beginning […]
MINNESOTA, United States–(BUSINESS WIRE)– Osprey Medical Inc.(ASX:OSP) today announced a multi-center observational study for the DyeVert Plus™ System will feature at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Session in April 2018. The abstract entitled: A Multi-Center Observational Study of the DyeVert Plus™ Contrast Reduction System summarizes a single-arm, multi-center observational […]
IRVINE, Calif., Feb. 15, 2018 /PRNewswire/ — Edwards Lifesciences(NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it has received CE Mark for its self-expanding CENTERA valve for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery. The Edwards CENTERA […]
HeartFlow Completes Series E Financing, Securing $240 Million Proceeds Will Support Commercialization of HeartFlow® FFRct Analysis, Continued Technology Innovation and Additional Clinical Studies REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow. today announced the closing of its Series E financing, securing $240 million. The company will use the proceeds from this financing to ramp up commercial […]
LivaNova to Acquire TandemLife Company will add advanced cardiopulmonary temporary support solutions to its portfolio LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has entered into an agreement to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions (“TandemLife”). The […]
